Public value in the field of health: conceptual frameworks and applications. A scoping review
e202611095
DOI:
https://doi.org/10.67113/resp.v100i1.1757Keywords:
Public value in health care, Health equity, Public value, Public value creation, Value-based health care, Scoping reviewAbstract
BACKGROUND // Despite the existence of value-based health care, the notion of public value in health care applied to Public Health and Public Health care systems has seen virtually no development. The aim of the study was to identify, describe and analyze existing conceptual approaches to Public Health value in health care, and its dimensions and implications.
METHODS // A scoping review was conducted in accordance with the PRISMA-ScR guidelines. The review was carried out in PubMed, Scopus and Web of Science to identify scientific articles, and was supplemented by an additional search for grey literature and other references. The synthesis was performed using an inductive categorical analysis.
RESULTS // 72 references were selected from 377 identified studies. The main approach developed was that of Porter, followed by those of the European Commission, Mazzucato, Moore and Gray, as the most notable. The concept of public value was identified in 21 studies, 8 of which specifically addressed the healthcare sector. This concept was absent from the remaining studies included in the review, which focused instead on value in healthcare.
CONCLUSIONS // This review enables the identification of conceptual frameworks and applications, as well as highlighting the existing conceptual gap regarding the notion of Public Health value, its limited presence and development in the scientific literature, and its application in Public Health services. The results highlight the need to move towards a specific conceptualisation of Public Health value that can guide the analysis, evaluation and design of Public Health policies from a perspective consistent with the public purpose of health systems in terms of equity and global health.
Downloads
References
1. Gilmore AB, Fabbri A, Baum F, Bertscher A, Bondy K, Chang HJ et al. Defining and conceptualising the commercial determinants of health. The Lancet. Abril de 2023;401(10383):1194-1213. doi: https://doi.org/10.1016/S0140-6736(23)00013-2 DOI: https://doi.org/10.1016/S0140-6736(23)00013-2
2. Ghebreyesus TA. Achieving health for all requires action on the economic and commercial determinants of health. The Lancet. Abril de 2023;401(10383):1137-1139. doi: https://doi.org/10.1016/S0140-6736(23)00574-3 DOI: https://doi.org/10.1016/S0140-6736(23)00574-3
3. Porter ME, Teisberg EO. Redefining Competition in Health Care. Harv Bus Rev [Internet]. Junio de 2004;June 2004(June). Disponible en: https://hbr.org/2004/06/redefining-competition-in-health-care
4. Porter ME, Teisberg EO. Redefining Health Care: Creating Value-based Competition on Results. Boston: Harvard Business Review Press; 2006.
5. Porter ME, Teisberg EO. How Physicians Can Change the Future of Health Care. JAMA J Am Med Assoc. 14 de marzo de 2007;297(10):1103-1111. DOI: https://doi.org/10.1001/jama.297.10.1103
6. Porter ME. A Strategy for Health Care Reform-Toward a Value-Based System. N Engl J Med. 9 de julio de 2009;361(2):109-112. doi: https://doi.org/10.1056/NEJMp0904131 DOI: https://doi.org/10.1056/NEJMp0904131
7. Moore MH. Gestión estratégica y creación de valor en el sector público. Barcelona: Paidós; 1998.
8. He W, Li M, Cao L, Liu R, You J, Jing F et al. Introducing value-based healthcare perspectives into hospital performance assessment: A scoping review. J Evid-Based Med. junio de 2023;16(2):200-215. doi: https://doi.org/10.1111/jebm.12534. PubMed PMID: 37228246. DOI: https://doi.org/10.1111/jebm.12534
9. Van Staalduinen DJ, Van Den Bekerom P, Groeneveld S, Kidanemariam M, Stiggelbout AM, Van Den Akker-Van Marle ME. The implementation of value-based healthcare: a scoping review. BMC Health Serv Res. 1 de marzo de 2022;22(1):270. doi: https://doi.org/10.1186/s12913-022-07489-2 DOI: https://doi.org/10.1186/s12913-022-07489-2
10. Zhang M, Bao Y, Lang Y, Fu S, Kimber M, Levine M et al. What Is Value in Health and Healthcare? A Systematic Literature Review of Value Assessment Frameworks. Value Health. Febrero de 2022;25(2):302-317. doi: https://doi.org/10.1016/j.jval.2021.07.005 DOI: https://doi.org/10.1016/j.jval.2021.07.005
11. WHO Country Office for India. A global review of value-based care: theory, practice and lessons learned [Internet]. New Delhi: World Health Organization, Country Office for India; 2025. p. 116. Disponible en: https://www.who.int/india/publications/i/item/9789290220121
12. Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. Febrero de 2005;8(1):19-32. doi: https://doi.org/10.1080/1364557032000119616 DOI: https://doi.org/10.1080/1364557032000119616
13. Grant MJ, Booth A. A typology of reviews: an analysis of 14 review types and associated methodologies. Health Inf Libr J. Junio de 2009;26(2):91-108. doi: https://doi.org/10.1111/j.1471-1842.2009.00848.x DOI: https://doi.org/10.1111/j.1471-1842.2009.00848.x
14. Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2 de octubre de 2018;169(7):467-473. doi: https://doi.org/10.7326/M18-0850 DOI: https://doi.org/10.7326/M18-0850
15. Porter ME. What Is Value in Health Care? N Engl J Med. 23 de diciembre de 2010;363(26):2477-2481. doi: https://doi.org/10.1056/NEJMp1011024 DOI: https://doi.org/10.1056/NEJMp1011024
16. European Commission. Directorate General for Health and Food Safety. Defining value in ‘value-based healthcare’ :report of the Expert Panel on Effective Ways of Investing in Health (EXPH). [Internet]. LU: Publications Office; 2019 [consultado 10 de abril de 2025]. Disponible en: https://data.europa.eu/doi/10.2875/872343
17. Mazzucato M. El valor de las cosas: quién produce y quién gana en la economía global. Barcelona: Taurus; 2019.
18. Gray M. Value based healthcare. BMJ. 27 de enero de 2017;j437. doi: https://doi.org/10.1136/bmj.j437 DOI: https://doi.org/10.1136/bmj.j437
19. Smith PC, Sagan A, Siciliani L, Panteli D, McKee M, Soucat A et al. Building on value-based health care. Towards a health system perspective. Copenhagen: WHO Regional Office for Europe; 2020. p. 27. Report Policy Brief 37.
20. Smith PC, Sagan A, Siciliani L, Figueras J. Building on value-based health care: Towards a health system perspective. Health Policy Amst Neth. Diciembre de 2023;138:104918. doi: https://doi.org/10.1016/j.healthpol.2023.104918. PubMed PMID: 37797445. DOI: https://doi.org/10.1016/j.healthpol.2023.104918
21. Cabinet Office. Public Design Evidence Review: Literature Review Paper 2-Public Value. [Internet]. 2025. Disponible en: https://assets.publishing.service.gov.uk/media/687a6d02312ee8a5f0806bc3/PDER_Literature_Review_2_Final.pdf
22. OECD, The Health Foundation. How Do Health System Features Influence Health System Performance? [Internet]. OECD Publishing; 2025 [consultado 16 de octubre de 2025]. Disponible en: https://www.oecd.org/en/publications/how-do-health-system-features-influence-health-system-performance_7b877762-en.html doi:10.1787/7b877762-en DOI: https://doi.org/10.1787/7b877762-en
23. Almazán C, Moharra M, Caro J, Ramírez A, Carrillo G. Salud participativa para una atencion centrada en el valor. Guía para la implementación de proyectos de atención sanitaria basada en el valor [Internet]. Barcelona: Agencia de Calidad y Evaluación Sanitarias de Cataluña. Departamento de Salud. Generalitat de Cataluña; 2021. Disponible en: https://aquas.gencat.cat/web/.content/minisite/aquas/publicacions/2021/guia_implementacion_proyectos_atencion_sanitaria_valor_aquas2021.pdf
24. Chief Medical Officer for Wales. Valuing our health | Chief Medical Officer’s Annual Report 2018/19. Welsh Government. p. 72.
25. Osakidetza. Estrategia de Valor en Osakidetza. Gobierno Vasco; julio de 2023. p. 80.
26. Raymond K, Haddock R, Nathan S, Harrison R, Meyer L. Value-based public health: Moving beyond value-based health care to support a wellbeing economy. Health Promot J Aust Off J Aust Assoc Health Promot Prof. Julio de 2023;34(3):675-680. doi: https://doi.org/10.1002/hpja.736. PubMed PMID: 37203255. DOI: https://doi.org/10.1002/hpja.736
27. González López-Valcárcel B, Ortún V, Errea M, Pinilla-Domínguez P. La economía de la salud en España: evidencia para la acción más allá de los costes. Gac Sanit. 2025;39:102516. doi: https://doi.org/10.1016/j.gaceta.2025.102516 DOI: https://doi.org/10.1016/j.gaceta.2025.102516
28. EIT Health. Implementing Value-Based Health Care in Europe: Handbook for Pioneers (Director: Gregory Katz) [Internet]. 2020. Disponible en: https://eithealth.eu/wp-content/uploads/2020/05/Implementing-Value-Based-Healthcare-In-Europe_web-4.pdf
29. Ernst & Young. El capital privado en el ámbito de la salud. Claves para generar valor en un sector de alto potencial [EY Insights]. Ernst & Young, S.L.; abril de 2025. (Health & Life Sciences).
30. KPMG. Contracting value: Shifting paradigms [Internet]. Abril de 2014. (HEALTHCARE). Disponible en: https://assets.kpmg.com/content/dam/kpmg/pdf/2014/12/contracting-value-v9.pdf
31. The Economist Intelligence Unit. An introduction to value-based healthcare in Europe [Internet]. London: The Economist; abril de 2015. Disponible en: https://impact.economist.com/health/introduction-value-based-healthcare-europe
32. World Economic Forum. Value in Healthcare. Laying the Foundation for Health System Transformation [Internet]. Geneva. Switzerland: WEF. In collaboration with The Boston Consulting Group; abril de 2017. Disponible en: https://www3.weforum.org/docs/WEF_Insight_Report_Value_Healthcare_Laying_Foundation.pdf
33. Reinhardt UE. HEALTH REFORM: Porter And Teisberg’s Utopian Vision. Health Aff Blog. 10 de octubre de 2006. doi: https://doi.org/10.1377/hblog20061010.000063
34. Groenewoud AS, Westert GP, Kremer JAM. Value based competition in health care’s ethical drawbacks and the need for a values-driven approach. BMC Health Serv Res. Diciembre de 2019;19(1):256. doi: https://doi.org/10.1186/s12913-019-4081-6 DOI: https://doi.org/10.1186/s12913-019-4081-6
35. Collington R, Mazzucato M. Beyond outsourcing: Re-embedding the state in public value production. Organization. Octubre de 2024;31(7):1136-1156. doi: https://doi.org/10.1177/13505084231163931 DOI: https://doi.org/10.1177/13505084231163931
36. Mazzucato M, Chow H, Fitzpatrick S, Laplane A, Masini T, McDonald D et al. The people’s prescription. Re-imagining health innovation to deliver public value. IIPP Policy Report, UCL Institute for Innovation and Public Purpose; 2018.
37. Mazzucato M, Adhanom Ghebreyesus T. Advancing the economics of health for all. The Lancet. Septiembre de 2024;404(10457):998-1000. doi: https://doi.org/10.1016/S0140-6736(24)01873-7 DOI: https://doi.org/10.1016/S0140-6736(24)01873-7
38. Mazzucato M, Roy V. Rethinking value in health innovation: from mystifications towards prescriptions. J Econ Policy Reform. 3 de abril de 2019;22(2):101-119. doi: https://doi.org/10.1080/17487870.2018.1509712 DOI: https://doi.org/10.1080/17487870.2018.1509712
39. Mazzucato M, Ryan-Collins J. Putting value creation back into “public value”: from market-fixing to market-shaping. J Econ Policy Reform. 2 de octubre de 2022;25(4):345-360. doi: https://doi.org/10.1080/17487870.2022.2053537 DOI: https://doi.org/10.1080/17487870.2022.2053537
40. Calabrò GE, D’Ambrosio F, Fallani E, Ricciardi W. Influenza Vaccination Assessment according to a Value-Based Health Care Approach. Vaccines. 8 de octubre de 2022;10(10):1675. doi: https://doi.org/10.3390/vaccines10101675 DOI: https://doi.org/10.3390/vaccines10101675
41. Mcintosh T. Bilateral Federalism, Value-Based Healthcare and the Future of Canadian Intergovernmental Diplomacy on Health. Healthc Policy Polit Sante. Mayo de 2023;18(4):26-42. doi: https://doi.org/10.12927/hcpol.2023.27095. PubMed PMID: 37486811; PubMed Central PMCID: PMC10370399. DOI: https://doi.org/10.12927/hcpol.2023.27095
42. Scottish Government, NHS Scotland. Value Based Health and Care Action Plan. The Scottish Government; 2023. 26 p.
43. WHO Council on the Economics of Health for All. Governing health innovation for the common good. noviembre de 2021. p. 15. Report COUNCIL BRIEF NO. 1.
44. Williams, Iestyn, Shearer H. Public Value and the English NHS: A review of the literature [Internet]. NHS Institute for Innovation and Improvement and Warwick Business School; 2010. Disponible en: https://www.academia.edu/30943166/Public_Value_and_the_English_NHS_A_review_of_the_literature
45. Nature Editorial. End GDP mania: how the world should really measure prosperity. Nature. 2 de octubre de 2025;646(8083):7-7. doi: https://doi.org/10.1038/d41586-025-03144-y DOI: https://doi.org/10.1038/d41586-025-03144-y
46. Stiglitz JE. Más allá del PIB. Project Syndicate [Internet]. 3 de diciembre de 2018. Disponible en: https://www.project-syndicate.org/commentary/new-metrics-of-wellbeing-not-just-gdp-by-joseph-e-stiglitz-2018-12/spanish
47. Stiglitz JE, Fitoussi JP, Durand M. Beyond GDP: Measuring What Counts for Economic and Social Performance [Internet]. OECD; 2018 [consultado 7 de abril de 2025]. Disponible en: https://www.oecd.org/en/publications/beyond-gdp_9789264307292-en.html. doi: https://doi.org/10.1787/9789264307292-en DOI: https://doi.org/10.1787/9789264307292-en
48. Stiglitz PJE, Sen PA, Fitoussi PJP. Report by the Commission on the Measurement of Economic Performance and Social Progress [Internet]. Commission on the Measurement of Economic Performance and Social Progress; 2009. Disponible en: https://ec.europa.eu/eurostat/documents/8131721/8131772/Stiglitz-Sen-Fitoussi-Commission-report.pdf
49. Australian Goverment. Measuring what matters: Australia’s first wellbeing framework. Commonwealth of Australia. Commonwealth of Australia; 2023. 127 p.
50. Reinhardt UE. Reflections on the Meaning of Efficiency: Can Efficiency Be Separated from Equity? Yale Law Policy Rev [Internet]. 1992;10(2/8):302-315. Disponible en: https://openyls.law.yale.edu/entities/publication/76613229-cdf5-4c5c-929d-9739b25eb263
51. Heath I. Back to the future: aspects of the NHS that should never change-an essay by Iona Heath. BMJ. 25 de julio de 2018;k3187. doi: https://doi.org/10.1136/bmj.k3187 DOI: https://doi.org/10.1136/bmj.k3187
52. Horton R. Offline: Not one day more. The Lancet. Julio de 2017;390(10090):110. doi: https://doi.org/10.1016/S0140-6736(17)31798-1 DOI: https://doi.org/10.1016/S0140-6736(17)31798-1
53. Horton R. Offline: Progress is possible, if we choose it. The Lancet. Octubre de 2024;404(10463):1627. doi: https://doi.org/10.1016/S0140-6736(24)02347-X DOI: https://doi.org/10.1016/S0140-6736(24)02347-X
54. McKee M, Balabanova D, Basu S, Ricciardi W, Stuckler D. Universal Health Coverage: A Quest for All Countries But under Threat in Some. Value Health. Enero de 2013;16(1):S39-45. doi: https://doi.org/10.1016/j.jval.2012.10.001 DOI: https://doi.org/10.1016/j.jval.2012.10.001
55. The Lancet. Supporting medical science in the USA. The Lancet. Abril de 2025;405(10488):1439. doi: https://doi.org/10.1016/S0140-6736(25)00814-1 DOI: https://doi.org/10.1016/S0140-6736(25)00814-1
56. Woolhandler S, Himmelstein DU, Ahmed S, Bailey Z, Bassett MT, Bird M et al. Public policy and health in the Trump era. The Lancet. Febrero de 2021;397(10275):705-753. doi: https://doi.org/10.1016/S0140-6736(20)32545-9 DOI: https://doi.org/10.1016/S0140-6736(20)32545-9
57. Gaffney A, Woolhandler S, Himmelstein DU, McCormick D. Health care in the USA: money has become the mission. The Lancet. Noviembre de 2025;406(10519):2588-2600. doi: https://doi.org/10.1016/S0140-6736(25)01669-1 DOI: https://doi.org/10.1016/S0140-6736(25)01669-1
Downloads
Additional Files
- FIGURA 1 (Español (España))
- TABLA 1 (a) (Español (España))
- TABLA 1 (b) (Español (España))
- TABLA 1 (c) (Español (España))
- TABLA 1 (d) (Español (España))
- TABLA 1 (e) (Español (España))
- TABLA 1 (f) (Español (España))
- TABLA 1 (g) (Español (España))
- TABLA 1 (h) (Español (España))
- TABLA 1 (i) (Español (España))
- TABLA 1 (j) (Español (España))
- TABLA 1 (k) (Español (España))
- TABLA 1 (l) (Español (España))
- TABLA 1 (m) (Español (España))
- TABLA 1 (n) (Español (España))
- TABLA 1 (o) (Español (España))
- TABLA 1 (p) (Español (España))
- TABLA 1 (q) (Español (España))
- TABLA 1 (r) (Español (España))
- TABLA 1 (s) (Español (España))
- TABLA 1 (t) (Español (España))
- TABLA 1 (u) (Español (España))
- TABLA 1 (v) (Español (España))
- TABLA 1 (w) (Español (España))
- TABLA 1 (x) (Español (España))
- ANEXO I (Español (España))
- ANEXO II (a) (Español (España))
- ANEXO II (b) (Español (España))
- ANEXO II (c) (Español (España))
- ANEXO II (d) (Español (España))
- ANEXO II (e) (Español (España))
Published
How to Cite
License
Copyright (c) 2026 Luis Gavira-Sánchez, Juan Manuel García-González, Manuel Pérez-Yruela

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.







![¿Cómo evaluar para la RESP? [PARA REVISORES]](https://ojs.sanidad.gob.es/public/site/images/rmartinb/pastilla-revisores-0eaa113abcbc4fc554c7c6c7840ca4c6.jpg)
![¿Cómo recibir avisos sobre nuevos artículos de la RESP? [PARA LECTORES]](https://ojs.sanidad.gob.es/public/site/images/rmartinb/pastilla-lectores-aa689338e95aab07df45b4b0d583188f.jpg)
